probucol has been researched along with Angor Pectoris in 6 studies
Probucol: A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
probucol : A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Study of the effect of antioxidant probucol on free-radical lipid peroxidation, blood rheology, and course of angina pectoris in coronary patients." | 7.70 | [Antioxidant probucol: effects on free radical lipid peroxidation, blood rheology and course of angina pectoris]. ( Mirionkova, NA; Shamaev, AG; Zakirova, AN, 1998) |
| "Thirty-eight men with chronic coronary heart disease (CHD) aged 38 to 65 years (ten patients with attendant obliterating atherosclerosis of lower extremity vessels) were treated with the hypolipidemic drug probucol in a dose of 1000 mg/day for three months." | 7.67 | [Effect of probucol on lipid metabolism and the clinical course of ischemic heart disease and arteriosclerosis obliterans of the vessels of the lower extremities]. ( Diukov, IV; Dudaev, VA; Gorin, VV; Kliuchnikova, ZhI; Shingireĭ, MV, 1984) |
| "Study of the effect of antioxidant probucol on free-radical lipid peroxidation, blood rheology, and course of angina pectoris in coronary patients." | 3.70 | [Antioxidant probucol: effects on free radical lipid peroxidation, blood rheology and course of angina pectoris]. ( Mirionkova, NA; Shamaev, AG; Zakirova, AN, 1998) |
| "The influence of probucol-induced low high-density lipoprotein (HDL) cholesterolemia on the progression of coronary atherosclerosis was studied in 320 patients with angina pectoris or myocardial infarction, 32 patients with probucol 500 mg/day, 288 patients without probucol, who underwent follow-up angiography at intervals of at least 2 years." | 3.69 | [Influence of low high-density lipoprotein cholesterolemia induced by probucol on the progression of coronary atherosclerosis]. ( Harada, S; Hiasa, Y; Hosokawa, S; Kato, S; Kishi, K; Ohtani, R; Takahashi, T; Tanimoto, M, 1997) |
| "Thirty-eight men with chronic coronary heart disease (CHD) aged 38 to 65 years (ten patients with attendant obliterating atherosclerosis of lower extremity vessels) were treated with the hypolipidemic drug probucol in a dose of 1000 mg/day for three months." | 3.67 | [Effect of probucol on lipid metabolism and the clinical course of ischemic heart disease and arteriosclerosis obliterans of the vessels of the lower extremities]. ( Diukov, IV; Dudaev, VA; Gorin, VV; Kliuchnikova, ZhI; Shingireĭ, MV, 1984) |
| "Probucol was well tolerated by child and adult patients." | 1.26 | Treatment of homozygous familial hypercholesterolaemia with probucol. ( Baker, SG; Joffe, BI; Mendelsohn, D; Seftel, HC, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagano, M | 1 |
| Nakamura, M | 1 |
| Kobayashi, N | 1 |
| Kamata, J | 1 |
| Hiramori, K | 1 |
| Dudaev, VA | 1 |
| Gorin, VV | 1 |
| Shingireĭ, MV | 1 |
| Kliuchnikova, ZhI | 1 |
| Diukov, IV | 1 |
| Baker, SG | 1 |
| Joffe, BI | 1 |
| Mendelsohn, D | 1 |
| Seftel, HC | 1 |
| Takahashi, T | 1 |
| Hiasa, Y | 1 |
| Harada, S | 1 |
| Hosokawa, S | 1 |
| Kato, S | 1 |
| Tanimoto, M | 1 |
| Kishi, K | 1 |
| Ohtani, R | 1 |
| Zakirova, AN | 1 |
| Shamaev, AG | 1 |
| Mirionkova, NA | 1 |
| Anikin, VV | 1 |
| Savin, VV | 1 |
| Lupanov, VP | 1 |
| Razygraev, RA | 1 |
1 trial available for probucol and Angor Pectoris
| Article | Year |
|---|---|
[Effect of probucol on cardiac electrophysiology in anginal patients with hyperlipidemia and diabetes mellitus type II].
Topics: Aged; Angina Pectoris; Anticholesteremic Agents; Biomarkers; Blood Glucose; Body Mass Index; Cardiac | 2000 |
5 other studies available for probucol and Angor Pectoris
| Article | Year |
|---|---|
Effort angina in a middle-aged woman with abnormally high levels of serum high-density lipoprotein cholesterol: a case of cholesteryl-ester transfer protein deficiency.
Topics: Angina Pectoris; Anticholesteremic Agents; Carrier Proteins; Cholesterol Ester Transfer Proteins; Ch | 2005 |
[Effect of probucol on lipid metabolism and the clinical course of ischemic heart disease and arteriosclerosis obliterans of the vessels of the lower extremities].
Topics: Adult; Aged; Angina Pectoris; Arteriosclerosis Obliterans; Chronic Disease; Coronary Disease; Drug E | 1984 |
Treatment of homozygous familial hypercholesterolaemia with probucol.
Topics: Adolescent; Adult; Angina Pectoris; Child; Cholesterol; Diet; Electrocardiography; Female; Follow-Up | 1982 |
[Influence of low high-density lipoprotein cholesterolemia induced by probucol on the progression of coronary atherosclerosis].
Topics: Aged; Angina Pectoris; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery | 1997 |
[Antioxidant probucol: effects on free radical lipid peroxidation, blood rheology and course of angina pectoris].
Topics: Angina Pectoris; Anticholesteremic Agents; Dose-Response Relationship, Drug; Electrocardiography, Am | 1998 |